Position in HIMS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$12,064
+$5,110 QoQ
Shares Held
348
+3.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#427
of 507 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SJS Investment Consulting Inc. holds $550,595 across 35 Drug Manufacturers - Specialty & Generic names. HIMS ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HROW |
Harrow, Inc.
|
6,073 | $257,920 | |
| 2 | ZTS |
Zoetis Inc.
|
770 | $55,331 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
255 | $42,977 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,285 | $36,627 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
54 | $29,258 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,180 | $29,039 | |
| 7 | VTRS |
Viatris Inc
|
895 | $14,212 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
This page
|
348 | $12,064 |
All Filings in HIMS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,064 | 348 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $6,954 | 335 | Shares | Sole | 2026-04-23 | |
| No filing history on record for this holder in this stock. | ||||||